Tianjin, China

Wenli Liu

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Tasly Pharmaceutical Group Co., Ltd.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wenli Liu. Retrieved from https://idiyas.com/inventor/wenli-liu-omrpsp09

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Profile of Inventor Wenli Liu: Innovating Silybin Injection

Introduction: Wenli Liu is an accomplished inventor based in Tianjin, China, known for his contributions to the field of pharmaceuticals. With a solid educational background and a commitment to innovation, he has made significant strides in developing new medical solutions.

Latest Patents: Wenli Liu holds a patent for a silybin injection and its preparation method. This innovation encompasses a formulation that includes silybin, sulfobutyl ether-β-cyclodextrin, an organic solvent for injection, and a pH regulator. The injection may also incorporate a co-solvent, a lyophilization bulking agent, and water for injection, reflecting the advanced nature of his work in drug development.

Career Highlights: As an integral part of the Tasly Pharmaceutical Group Co., Ltd., Wenli Liu has applied his expertise to enhance pharmaceutical formulations and improve patient outcomes. His innovative spirit and dedication to research have contributed to the advancement of modern medicine.

Collaborations: Throughout his career, Wenli Liu has worked alongside fellow professionals in the field, such as Jianming Chen and Baoan Gao. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.

Conclusion: Wenli Liu's contributions to the field of pharmacology, particularly with his patent for silybin injection, demonstrate his commitment to innovation and improving healthcare. As he continues his work at Tasly Pharmaceutical Group Co., Ltd., the potential for further advancements remains bright.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…